Evidence map›Paper›PMID 42853873›Full record

ArticlePLoS neglected tropical diseases2026

A multiregional serosurvey of RNA virus-reactive antibodies in bats and rodents reveals the enzootic presence of flavi- and paramyxoviruses in African Pteropodidae.

Jackson Emanuel, Jan Papies, Leonie Meiners, Talitha Veith, Victor M Corman, Tabea Binger, Erik Lattwein, Beate M Kümmerer, Susanne Zweerink, Kai Fechner and 14 more

Abstract read
PubMed Publisher
In one paragraph

Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Jackson EmanuelInstitute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0002-6246-5255
Jan PapiesInstitute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Leonie MeinersInstitute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Talitha VeithInstitute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Victor M CormanInstitute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Tabea BingerInternational Vaccine Institute (IVI), Seoul, Korea.
Erik LattweinInstitute for Experimental Immunology, affiliated to EUROIMMUN Medizinische Labordiagnostika AG, Lübeck, Germany.
Beate M KümmererInstitute of Virology, Medical Faculty, University of Bonn, Bonn, Germany.
Susanne ZweerinkDepartment of Gastroenterology and Hepatology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
Kai FechnerInstitute for Experimental Immunology, affiliated to EUROIMMUN Medizinische Labordiagnostika AG, Lübeck, Germany.
Florian Gloza-RauschMuseum für Naturkunde, Leibniz Institute for Evolution and Biodiversity Science, Berlin, Germany.
Veronika CottontailDepartment of Medicine II, Division of Infectious Diseases and Tropical Medicine, University Hospital Würzburg, Würzburg, Germany.
Gaël D MagangaCentre Interdisciplinaire de Recherches Médicales de Franceville (CIRMF), Franceville, Gabon.
Jonas Schmidt-ChanasitDepartment of Arbovirology and Entomology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Peter ValloInstitute of Vertebrate Biology, Czech Academy of Sciences, Brno, Czech Republic.
Samuel K OppongDepartment of Wildlife and Range Management, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Marco TschapkaSmithsonian Tropical Research Institute, Ancon, Panama.
Chantal B E M ReuskenCenter for infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Rainer G UlrichInstitute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
Eric M LeroyRecherches translationnelles sur le VIH et les maladies infectieuses (TransVIHMI), Université de Montpellier-IRD-Inserm, Montpellier, France.
Jan Felix DrexlerInstitute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Terry C JonesInstitute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Christian DrostenInstitute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Marcel A MüllerInstitute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0003-2242-5117

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bats and rodents have been identified as reservoir hosts of diverse RNA viruses that pose potential risks to humans. However, overall virus prevalence in wildlife and underlying factors determining the zoonotic potential of reservoir-borne viruses remain poorly characterized. Virus detection often relies on the identification of viral nucleotide sequences and may therefore be limited by variable virus concentration, tissue tropism, sample quality, and duration of infection. In this study, we applied a multiplex immunofluorescence assay to examine bat and rodent seroprevalence against 14 different human pathogenic RNA viruses spanning seven virus families (Coronaviridae, Flaviviridae, Hantaviridae, Paramyxoviridae, Phenuiviridae, Pneumoviridae, Togaviridae). We retrospectively analyzed 1,135 bat (16 species) and 454 rodent (14 species) blood or transudate specimens collected at 63 sites in seven countries. The tropical bats in our dataset exhibited notably high rates of seropositivity against certain virus families (Flaviviridae: 42.7%; Paramyxoviridae: 67.7%; Togaviridae: 7.5%). Although confounding factors and sparse data continue to pose challenges to identifying correlates of RNA virus infection in wildlife, multivariable logistic regression models were created to provisionally evaluate the association of tropical bat characteristics with seropositivity. Preliminary findings indicate that large colony size, found among species such as Eidolon helvum and Rousettus aegyptiacus, is a predictor within this dataset of orthoflavi- and orthorubulavirus seroprevalence, consistent with the communal spread of bat-adapted viruses.

Indexed as

Antibodies, ViralChiropteraFlaviviridaeParamyxoviridaeParamyxoviridae InfectionsRodentiaAfricaAnimalsDisease ReservoirsParamyxovirinaeRetrospective StudiesSeroepidemiologic StudiesAntibodies, Viral

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.